Trouble at the core: BRAF(V600E) drives multiple modes of T-cell suppression in melanoma

DOI: 10.1080/2162402X.2015.1078966

Keywords: BRAF V600E, Cancer, Cytotoxic T cell, HLA, immune suppression, immunotherapy, interleukin-1, MHC class I, melanoma, oncogene, oncogene targeted therapies

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text